LINC New York @ Mount Sinai took place on
11–12 June 2019
at the Mount Sinai Hospital,
New York, The United States
On June 11, Prof. Dierk Scheinert presented on behalf of the principal investigator, Prof. Guo Wei, the latest 5 year safety and efficacy data from the randomized AcoArt I study, comparing the Orchid DCB vs. POBA in a total of 200 patients.
FDA Breakthrough Device Designation
On June 5 Acotec’s Litos Paclitaxel Releasing Peripheral Balloon Dilatation Catheter has been granted designation for the Breakthrough Device Programme to investigate its indication for treatment of de novo and restenotic infrapopliteal lesions.
For more information please visit congress website.